Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07532070

COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIAL

This study aims to find out which lifestyle approach works best for people with chronic musculoskeletal pain (such as low back pain or hip/knee osteoarthritis) who also have poor sleep. Participants will be randomly assigned to one of three 12-month home-based programs: exercise, cognitive behavioral therapy for insomnia (CBT-I), or a combination of both. Each program includes up to 10 online sessions with a physiotherapist and guidance on managing pain, sleep, and physical activity. We will measure changes in pain, sleep quality, and overall health using questionnaires, wearable devices, sensory tests, and blood samples. The goal is to improve understanding of non-medication treatments for pain and sleep problems.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Chronic musculoskeletal pain, such as low back pain and osteoarthritis of the hip or knee, is common and often associated with poor sleep, reduced function, and lower quality of life. Lifestyle factors like exercise and sleep management can influence pain and well-being, but it is unclear which approach works best for people with both chronic pain and sleep problems.

This randomized controlled trial will compare the effectiveness of three 12-month home-based lifestyle interventions:

Exercise program Cognitive Behavioral Therapy for Insomnia (CBT-I) Combination of exercise and CBT-I

Participants will be adults with chronic low back pain and/or hip or knee osteoarthritis lasting at least 6 months, who also report poor sleep. Eligible participants will be randomly assigned to one of the three groups. All groups will receive up to 10 online consultations with a physiotherapist over 9 months, plus tailored guidance on pain, sleep, and physical activity.

Assessments will occur at baseline, 2 months, 6 months, and 12 months, and will include:

Online questionnaires on pain, sleep, and quality of life Wearable activity and sleep monitoring Sensory testing Blood samples to explore biological markers related to pain and sleep Sleep EEG recordings at baseline and 6 months

The primary aim is to determine which lifestyle intervention provides the greatest improvement in pain and sleep outcomes. Secondary aims include understanding changes in physical function, mood, and biological markers. Findings will help guide future non-medication treatments for people with chronic pain and sleep difficulties.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants will be included if they have persistent LBP defined as i) age ≥18 years; ii) sought or seriously considered care from a primary care clinician or specialist for their LBP within the past 6 weeks; iii) have at least moderate LBP-related interference with normal work or daily activity (including both work outside the home and housework), as assessed by item 8 of the 36-item Short Form Health Survey OR hip or knee OA defined by the National Institute for Health and Care Excellence as: i) age ≥45 years; ii) activity-related hip or knee joint pain; and iii) no morning hip or knee stiffness, or morning stiffness ≤30 minutes)

  • An average pain of ≥4 on an 11-point numerical rating scale (NRS); 0 equals no pain, 10 equals worst pain possible over the last week
  • ≥11 on the Insomnia Severity Index
  • Access to a computer/laptop/tablet with internet availability for videoconferencing consultations
  • Willing and able to participate in video consultations
  • Verification that participants recruited in the US are beneficiaries of the Military Health System.

Exclusion criteria

  • Self-report engagement in >120 minute per week of at least moderate intensity physical activity within the past 6 months
  • Current or previous engagement in CBT-I in the past 6 months
  • Cognitive impairment (based on ≥7 on the Short Orientation Memory Concentration Test
  • Received an injection of any substance into the study pain site in the previous 3 months
  • Waiting or planning to receive an injection in the study pain site in the next 12 months
  • Had within the past 12 months, or waiting or planning surgery in the next 12 months
  • Neurological or systemic conditions that may affect physical function (e.g. Parkinson's, Active cancers, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis)
  • Failing the American College of Sports Medicine pre-participation Health Screening Questionnaire without medical clearance to participate
  • Unable to give informed consent and/or participate in the intervention and assessment procedures.
  • Unable to speak or read English.

Treatment and study plan

Aerobic physical activity

Behavioral

This intervention consists of a structured, individualised aerobic physical activity program delivered via videoconferencing by a physiotherapist. The program focuses exclusively on aerobic-based activities and does not include any sleep-specific or cognitive behavioural components. Exercise prescription will be tailored and progressively adjusted based on participant tolerance, goals, and clinical guidelines.

CBT-I

Behavioral

This intervention consists of cognitive behavioural therapy for insomnia (CBT-I) delivered via videoconferencing by a physiotherapist trained in CBT-I principles. The program targets sleep-related behaviours and cognitions using evidence-based CBT-I strategies, including sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene education. No structured physical activity or exercise prescription is included.

Combined aerobic physical activity and CBT-I

Behavioral

This intervention integrates both a structured aerobic physical activity program and cognitive behavioural therapy for insomnia (CBT-I) within the same physiotherapist-delivered videoconferencing consultations. Participants receive both aerobic physical activity alongside CBT-I strategies targeting sleep behaviours and cognitions. The combined intervention delivers both components concurrently and differs from the single-component interventions by addressing physical aerobic activity and sleep within an integrated treatment framework.

Primary outcomes

  1. Average Pain severity

    Time frame: Baseline and 2, 6 (primary time-point) and 12 months

    Average pain severity at the designated study site will be measured using a 0-10 Numerical Rating Scale, with higher scores indicating greater pain. Assessments will be conducted at baseline and at 2, 6, and 12 months. Primary intervention efficacy will be evaluated by between-group differences in change in average NRS pain from baseline to 6 months.

Secondary outcomes

  1. Worst pain severity

    Time frame: Baseline and 2, 6 and 12 months

    Worst pain severity at the designated study site over the past week will be assessed using the numeric rating scale, ranging from 0 ("no pain") to 10 ("worst pain possible").

  2. Pain interference (PROMIS Short Form 8a)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 8 questions (5-point Likert Scale) related to the consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities in the past 7 days. 5-point Likert scale. Ranges from 0-10; where 0 = 'no pain' and 10 = 'worst pain possible'

  3. Health-related quality of life (EQ-5D-5L)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 5 items (5-point Likert Scale) about mobility, self-care, pain, usual activities, and psychological status over the past week, with a Likert scale ranging from no problem to extreme pain or discomfort.Score ranges from 0 to 100. Higher scores indicate a better quality of life.

  4. Insomnia (Insomnia Severity Index)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using a 7-items (5-point Likert scale) that captures disturbances in sleep consistent with insomnia. Score ranges 0 to 28. Higher scores indicating greater insomnia severity.

  5. Sleep-related impairment (PROMIS-Sleep-related Impairment Short Form 8a)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 8 items (5-point Likert scale) on perceptions of alertness, sleepiness, and tiredness during usual waking hours, and perceived functional impairments during wakefulness associated with sleep or impaired alertness. Ranging from "very poor/not at all" to "very good/very much". Score ranges from 8 to 40. Higher scores indicate greater sleep-related impairments.

  6. Physical Function (PROMIS-Physical Function Short Form 8c v2.0)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 8 items on 5 point Likert scales, capturing capacity to perform activities such as household chores, walking, climbing stairs, and lifting, as well as whether health limits these activities Ranging from "without any difficulty/not at all" to "unable to do/cannot do". Score ranges from 8 to 40. Higher scores indicate less physical dysfunction.

  7. Satisfaction with the intervention

    Time frame: 2 mths, 12 months

    Self-reported. Evaluation as perceived satisfaction. Ranging from "strongly agree" to "strongly disagree". Score range from 0 to 44 with higher score indicating less satisfaction.

Other outcomes

  1. Physical activity

    Time frame: 2-12 months

    Time spent in at least moderate intensity activity per week using a wrist-worn wearable. Time (minutes)

  2. Psychological (Orthopaedic Physical Therapy Investigators Network Yellow Flag (10-items)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 10-item (various point Likert scales) about psychological distress (e.g. negative mood, fear-avoidance and positive coping). Ranging from 0 to 11 "yellow flags". Higher number indicates more yellow flags.

  3. Physiological sleep

    Time frame: 0-12 months

    Sleep efficiency (wearable).

    Time asleep relative to time in bed

  4. Medication use

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Self-reported using customised survey. Will report the number or percentage of participants for each type of medication.

  5. Co-interventions

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Self-reported using customised survey. Will report the number or percentage of participants for each type of co-intervention.

  6. Adverse events

    Time frame: Throughout 0-2 months, 6 and 12 months

    Physio treatment notes on REDCap (0-2 months) and self reported by participant at 6 months and 12 months also on REDcap. The number and type of events, related to this study.

  7. Sleep disturbance (PROMIS-Sleep Disturbance Short Form v1.0 8a)

    Time frame: Baseline, 2 mths, 6 and 12 months.

    Scored using 8 items (5-point Likert scale) on perceptions of sleep quality, depth, difficulties falling asleep and staying asleep, as well as sleep satisfaction over the past 2 weeks. Ranging from "very poor/not at all" to "very good/very severe". Score ranges from 8 to 40. Higher scores indicate greater sleep disturbances.

Study contacts

Contact information is provided by the study sponsor or research team.

Alan A Nguyen, BSc/B.A

CONTACT

[email protected]

+610433014884

Michelle Hall, PhD, MSc, BSc (Hons)

CONTACT

[email protected]

+61 432128223

Sponsors and collaborators

Lead sponsor

University of Sydney

Other

Collaborators

  • The University of Queensland
  • Uniformed Services University of the Health Sciences

Registry information

Acronym: SLEEPFIT

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Apr 15, 2026
Registry last updated
May 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.